These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 6894694)

  • 1. Orcein-positive hepatocytes in hepatitis B: morphologic evidence of chronic hepatitis B virus infection?
    Karasawa T; Shikata T; Abe K; Tanaka K; Ueda T; Kunugi M; Oda T
    Arch Pathol Lab Med; 1981 Jul; 105(7):388. PubMed ID: 6894694
    [No Abstract]   [Full Text] [Related]  

  • 2. Two distinct types of hepatitis in experimental hepatitis B virus infection.
    Shikata T; Karasawa T; Abe K
    Am J Pathol; 1980 May; 99(2):353-68. PubMed ID: 7377287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Heterogeneity of host response to hepatitis B virus].
    Sarno EN; Ruzany F; Vieira LM; Landmann J
    Rev Inst Med Trop Sao Paulo; 1982; 24(5):303-9. PubMed ID: 7167709
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunisation against hepatitis B.
    Gust ID; Lucas CR
    Aust Fam Physician; 1983 Sep; 12(9):657-60. PubMed ID: 6651631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver histology in patients with HBsAg negative anti-HBc and anti-HCV positive chronic hepatitis.
    Sagnelli E; Pasquale G; Coppola N; Marrocco C; Scarano F; Imparato M; Sagnelli C; Scolastico C; Piccinino F
    J Med Virol; 2005 Feb; 75(2):222-6. PubMed ID: 15602732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunofluorescence microscopy in experimentally induced, type B hepatitis in the chimpanzee.
    Hoofnagle JH; Michalak T; Nowoslawski A; Gerety RJ; Barker LF
    Gastroenterology; 1978 Feb; 74(2 Pt 1):182-7. PubMed ID: 340320
    [No Abstract]   [Full Text] [Related]  

  • 7. Study of antibody to hepatitis-B virus core antigen (anti-HBc) in chronic diffuse liver disease.
    Dávid K; Halmy L
    Acta Med Acad Sci Hung; 1982; 39(3-4):161-8. PubMed ID: 7185241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunohistochemical study of hepatitis B surface and core antigens in HBsAg seronegative and seropositive organ and tissue donors].
    Rékó G
    Orv Hetil; 1993 Aug; 134(33):1805-8. PubMed ID: 8351146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of hepatitis B core antigen and beta-catenin expression on hepatocytes in chronic hepatitis B virus infection: relevance to the severity of liver damage and viral replication.
    Kim CW; Yoon SK; Jung ES; Jung CK; Jang JW; Kim MS; Lee SY; Bae SH; Choi JY; Choi SW; Han NI; Lee CD
    J Gastroenterol Hepatol; 2007 Sep; 22(9):1534-42. PubMed ID: 17559383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes.
    Mondelli M; Vergani GM; Alberti A; Vergani D; Portmann B; Eddleston AL; Williams R
    J Immunol; 1982 Dec; 129(6):2773-8. PubMed ID: 6982941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and serological evaluation of surface antigen negative hepatitis B virus infection in blood donors from Venezuela.
    Gutiérrez C; Devesa M; Loureiro CL; León G; Liprandi F; Pujol FH
    J Med Virol; 2004 Jun; 73(2):200-7. PubMed ID: 15122793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flowcytometric quantitation of hepatitis B viral antigens in hepatocytes from regular and fine-needle biopsies.
    van der Laan LJ; Taimr P; Kok A; Sprengers D; Zondervan PE; Tilanus HW; Janssen HL
    J Virol Methods; 2007 Jun; 142(1-2):189-97. PubMed ID: 17328969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indian palm tree squirrel hepatitis B virus infection model for the human hepatitis.
    Mehrotra R; Srivastava S
    Indian J Med Res; 1987 Feb; 85():113-9. PubMed ID: 3596679
    [No Abstract]   [Full Text] [Related]  

  • 14. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B vaccine: current progress and strategies for utilization.
    Maynard JE
    Prog Clin Biol Res; 1980; 47():157-68. PubMed ID: 7208509
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention of de novo hepatitis B virus infection by vaccination and high hepatitis B surface antibodies level in children receiving hepatitis B virus core antibody-positive living related donor liver: case reports.
    Jankowska I; Pawłowska J; Teisseyre M; Kaliciński P; Kamiński A; Czubkowski P; Cielecka-Kuszyk J; Kluge P; Pronicki M; Socha J
    Transplant Proc; 2007 Jun; 39(5):1511-2. PubMed ID: 17580175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent developments in the diagnosis and monitoring of HBV infection and role of the genetic variability of the S gene.
    Weber B
    Expert Rev Mol Diagn; 2005 Jan; 5(1):75-91. PubMed ID: 15723594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electron and immunoelectron microscopic study of Dane particle formation in chronic hepatitis B virus infection.
    Yamada G; Sakamoto Y; Mizuno M; Nishihara T; Kobayashi T; Takahashi T; Nagashima H
    Gastroenterology; 1982 Aug; 83(2):348-56. PubMed ID: 7084614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioimmunoassay detection of IgM antibodies to the hepatitis B core antigen in HBsAg liver disease.
    Lavarini C; Crivelli O; Smedile A; Farci P; Marinucci G; Muglia M; Rizzetto M
    Boll Ist Sieroter Milan; 1982; 61(3):210-7. PubMed ID: 6985422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B core antibody-positive grafts: recipient's risk.
    de Villa VH; Chen YS; Chen CL
    Transplantation; 2003 Feb; 75(3 Suppl):S49-53. PubMed ID: 12589141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.